reiter buy pt
messag zoeti strong beat top bottom line
rais guidanc excess quarterli beat zoeti note expect derm revenu
strength expect off-set
weak livestock final zoeti expect first market
tripl flea tick heartworm estim could becom drug
reiter buy rate rais pt
zoeti nice beat-and-rais quarter top bottom line companion
anim led way asf challeng complet mask strong growth
dermatolog simparica zoeti even rais expect dermatolog revenu apoquel
cytopoint thesi zoeti big three enough growth
sustain current expect pipelin includ tripl pain product
provid long-term growth
tripl zoeti reiter remain time tripl flea tick heartworm
worm first half aim furthermor zoeti
confid first market given seen competitor seed market
delta first market second could mean annual
revenu depend gap perspect nexgard first market
origin flea tick chewabl estim revenu bravecto
pain zoeti announc file us eu osteoarthr pain treat
monoclon antibodi cat cat market larg popul significantli under-
medic although cat market requir signific educ like zoeti
think time could grow roughli size dog market estim
revenu driven strong companion anim report revenu
year year oper basi includ impact
abaxi acquisit vs note zoeti report growth
make beat even impress result consensu
estim
ep record ep year year vs
consensu estim record adjust ep
year year vs consensu estim
guidanc zoeti updat revenu guidanc given prior quarter
midpoint
midpoint greater beat increas ep guidanc
midpoint midpoint rais adjust ep
midpoint midpoint
companion anim zoeti companion anim segment saw revenu grow
compar consensu estim
estim domest companion anim
intern
livestock livestock saw revenu compar
consensu estim estim domest livestock
intern
page analyst certif import disclosur
model increas revenu estim
respect increas
adjust ep estim respect
valuat assum current trade multipl hold appli adj ep
previous estim arriv pt previous
believ multipl warrant given confid abil util
tripl monoclon antibodi pain contribut growth compani
figur revenu vs gsr consensu estim except ep
figur guidanc vs prior except ep
currenc risk difficulti expand margin
page analyst certif import disclosur
mm except guidanc anim
non-gaap sale
non-gaap provis tax
net incom alloc non-controlling interest
less net loss /incom attribut non-controlling interest
page analyst certif import disclosur
